
Serious side effects of treatment of localized prostate cancer affect urinary, bowel and sexual function. Recent evidence has suggested that for patients undergoing radical prostatectomy, urologists with a lot of practice prostatectomy, perhaps the best patient results. Although historically, reports of these side effects in the literature, as a rule, they alerted physicians to the retrospective analysis, there is a lot of effort by many researchers using modern quality of life assessment tools to quantify more precisely the impact of local therapy on long-term quality of life. These estimates should be used by patients and doctors to help make decisions about treatment. Cryotherapy is another modality of local treatment for prostate cancer, who were originally thrown out because of its high rate of complications. Recently, this modality of treatment regained momentum, new and improved tools and methods enable reduction of toxicity and, possibly, and greater efficiency. Currently, cryotherapy is still experimental in the United States. Hormonal ablationhas therapyandrogen more than 60 years is the primary initial treatment of patients with metastatic prostate cancer. Androgen ablation options for patients with advanced prostate cancer include levaquin mg bilateral orchiectomy, luteinizing hormone hormonereleasing (LHRH) analogues and antagonists, and combined androgen blockade, or a combination of orchiectomy or LHRH analogue plus an antiandrogen.
No comments:
Post a Comment